Sodium-glucose cotransporter type 2 inhibitors: A new era in the pharmacological treatment of heart failure with reduced ejection fraction?

Abstract

Due to the increase in the use of bioprosthetic valves, structural valve degeneration will become prevalent. Transcatheter aortic valve replacement (TAVR) represents a safe and effective alternative to redo surgery. We present a case of valve in valve (ViV) implantation with an unfortunate result.